Guangzhou Houbao Investment Partnership (Limited Partnership) signed a share transfer agreement to acquire 5.04% stake in Xiamen Amoytop Biotech Co., Ltd. (SHSE:688278) from Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) for approximately CNY 410 million on March 16, 2022. As per the transaction, Guangzhou Houbao Investment Partnership (Limited Partnership) will acquire 20.5 million shares at CNY 20.16 per share . The transaction is subject to approval by Shanghai Stock Exchange.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.9 CNY | -1.21% |
|
-5.42% | +1.05% |
04-22 | Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-18 | China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6% | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.05% | 2.96B | |
+1.88% | 94B | |
-0.13% | 39.05B | |
-10.43% | 33.74B | |
+77.76% | 28.54B | |
-14.82% | 15.59B | |
-3.06% | 13.69B | |
-12.76% | 11.44B | |
+181.73% | 10.66B | |
-53.92% | 9.27B |
- Stock Market
- Equities
- 688278 Stock
- News Xiamen Amoytop Biotech Co., Ltd.
- Guangzhou Houbao Investment Partnership (Limited Partnership) signed a share transfer agreement to acquire 5.04% stake in Xiamen Amoytop Biotech Co., Ltd. from Tonghua Dongbao Pharmaceutical Co., Ltd. for approximately CNY 410 million.